ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,868.55
-0.22%
US Tech 100
20,490.00
0.40%
Dow Jones
42,392.27
-0.36%
Brent Oil
75.695
-0.21%
Bitcoin
96,718.82
-0.18%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mustang Bio Inc (MBIO)

  7. Mustang Bio Inc (MBIO) News

MBIO

Mustang Bio (MBIO)

Mustang Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MBIO
DateTimeSourceHeadlineSymbolCompany
01/02/20254:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
12/06/20245:00PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MBIOMustang Bio Inc
12/02/20244:45PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
11/29/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
11/22/20244:45PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
11/15/20244:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
11/12/20248:30AMGlobeNewswire Inc.Mustang Bio Receives Positive Listing Determination from NasdaqNASDAQ:MBIOMustang Bio Inc
11/08/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBIOMustang Bio Inc
11/07/20248:30AMGlobeNewswire Inc.Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant GliomaNASDAQ:MBIOMustang Bio Inc
11/06/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
10/29/20244:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
10/25/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
10/24/20242:10PMGlobeNewswire Inc.Mustang Bio Announces Exercise of Warrants for $4 Million Gross ProceedsNASDAQ:MBIOMustang Bio Inc
09/13/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
08/16/20245:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
08/13/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MBIOMustang Bio Inc
07/30/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
07/19/20245:26PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
07/10/20244:41PMEdgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:MBIOMustang Bio Inc
06/21/20244:01PMGlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
06/20/20248:00AMGlobeNewswire Inc.Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
06/20/20248:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
06/17/20248:30AMGlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:MBIOMustang Bio Inc
06/13/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
06/06/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
06/04/20248:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
06/04/20248:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
05/31/20245:09PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
05/21/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
05/13/20246:01AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
 Showing the most relevant articles for your search:NASDAQ:MBIO

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
NASDAQ
TSLA
Tesla
USOTC
QNCCF
Quantum eMotion (QB)
USOTC
FDCT
FDCTech (CE)
USOTC
IQST
iQSTEL (QX)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
AFFU
Affluence (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
NVDA
NVIDIA
USOTC
CEOS
CeCors (PK)
USOTC
APRU
Apple Rush (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads